Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14901006 | 0.87 | PTPN1 (0.38) | PDE4BPTPN1MEN1KMT2AHSD11B1 | |
| SCHEMBL12831493 | 0.80 | PTPN1 (0.39) | PDE4BPTPN1MEN1KMT2AL3MBTL1 | |
| SCHEMBL19729138 | 0.79 | PTPN1 (0.34) | PDE4BPTPN1MEN1KMT2AL3MBTL1 | |
| SCHEMBL17370238 | 0.78 | KDM1A (0.33) | PTPN1IDO1L3MBTL1NPC1RAB9A | |
| SCHEMBL16035389 | 0.77 | ALDH1A1 (0.39) | PDE4BPTPN1MEN1KMT2AIDO1 | |
| SCHEMBL10058953 | 0.77 | ALDH1A1 (0.41) | PDE4BPTPN1MEN1KMT2AIDO1 | |
| SCHEMBL23907105 | 0.77 | PDE4B (0.39) | PDE4BPTPN1MEN1KMT2AL3MBTL1 | |
| SCHEMBL566227 | 0.76 | L3MBTL1 (0.35) | PTPN1MEN1KMT2AIDO1L3MBTL1 | |
| SCHEMBL23420929 | 0.76 | PTPN1 (0.35) | PDE4BPTPN1IDO1L3MBTL1HSD11B1 | |
| SCHEMBL15100430 | 0.75 | PTPN1 (0.35) | PDE4BPTPN1MEN1KMT2AIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362508-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | DIC CORPORATION (JP) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362508-A1 | POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY | PBDC1, RCC1, PUF60 | PDE4B 2048/4885PTPN1 4420/4885MEN1 2412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.